• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Portugal Telecom SA ADR

Portugal Telecom SA ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Takeda and Seattle Genetics Report Positive Phase 3 ALCANZA Clinical Trial Data of ADCETRIS® (Brentuximab Vedotin) for CD30-Expressing Cutaneous T-Cell Lymphoma

    Takeda and Seattle Genetics Report Positive Phase 3 ALCANZA Clinical Trial Data of ADCETRIS® (Brentuximab Vedotin) for CD30-Expressing Cutaneous T-Cell Lymphoma

  2. bluebird bio Presents New Data from HGB-205 Study of LentiGlobinTM Drug Product in Patients with Transfusion-Dependent β-Thalassemia (TDT) and Severe Sickle Cell Disease at American Society of ...

    bluebird bio Presents New Data from HGB-205 Study of LentiGlobinTM Drug Product in Patients with Transfusion-Dependent β-Thalassemia (TDT) and Severe Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting

  3. Seattle Genetics Presents Data from Phase 2 Study Evaluating ADCETRIS® (Brentuximab Vedotin) in Frontline Diffuse Large B-cell Lymphoma at ASH Annual Meeting

    Seattle Genetics Presents Data from Phase 2 Study Evaluating ADCETRIS® (Brentuximab Vedotin) in Frontline Diffuse Large B-cell Lymphoma at ASH Annual Meeting

  4. Seattle Genetics Presents Phase 1b Data from Vadastuximab Talirine (SGN-CD33A; 33A) in Combination with Standard of Care in Frontline Acute Myeloid Leukemia at ASH Annual Meeting

    Seattle Genetics Presents Phase 1b Data from Vadastuximab Talirine (SGN-CD33A; 33A) in Combination with Standard of Care in Frontline Acute Myeloid Leukemia at ASH Annual Meeting

  5. Acme United Corporation to Present at LD Micro Main Event Conference on December 6, 2016

    Acme United Corporation to Present at LD Micro Main Event Conference on December 6, 2016

  6. NIKE, Inc. Announces Second Quarter Fiscal 2017 Earnings and Conference Call

    NIKE, Inc. Announces Second Quarter Fiscal 2017 Earnings and Conference Call

  7. Xenetic Biosciences to Present at the LD Micro 2016 Annual Conference

    Xenetic Biosciences to Present at the LD Micro 2016 Annual Conference

  8. UPDATE: Cyber Monday sales results show mobile investments are paying off

    UPDATE: Cyber Monday sales results show mobile investments are paying off

  9. UPDATE: Cyber Monday goes mobile, breaks $1 billion in sales

    UPDATE: Cyber Monday goes mobile, breaks $1 billion in sales

  10. CORRECTING and REPLACING Rocket Fuel to Present at Upcoming Investor Conference

    CORRECTING and REPLACING Rocket Fuel to Present at Upcoming Investor Conference

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.